Why is Venmax Drugs falling/rising?

As of 15-Jul, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with the current price at 24.81, reflecting a change of 0.48 or 1.97% upward. The stock has shown a strong performance today, outperforming its sector by 0.72% and has been on a consecutive gain streak for the last four days, accumulating a total return of 8.1% during this period. However, it is important to note that the delivery volume has significantly decreased by 77.84% compared to the 5-day average, indicating a decline in investor participation. The stock's performance over the past week shows a 5.98% increase, contrasting with a decline of 10.66% over the past month, while it has a year-to-date return of 37.53%.
In the broader market context, the stock's recent gains come amid a decline in the benchmark Sensex, which has fallen by 1.36% over the past week. This indicates that Venmax's performance is relatively strong compared to the market trend. While the stock has outperformed the sector recently, the significant drop in delivery volume suggests caution among investors, which could impact future price movements. Overall, despite the positive short-term performance, the falling investor participation may raise concerns about the sustainability of the stock's upward trajectory.